PE13395A1 - Composicion farmaceutica de imidazolil carbazolona - Google Patents
Composicion farmaceutica de imidazolil carbazolonaInfo
- Publication number
- PE13395A1 PE13395A1 PE1994242905A PE24290594A PE13395A1 PE 13395 A1 PE13395 A1 PE 13395A1 PE 1994242905 A PE1994242905 A PE 1994242905A PE 24290594 A PE24290594 A PE 24290594A PE 13395 A1 PE13395 A1 PE 13395A1
- Authority
- PE
- Peru
- Prior art keywords
- pharmaceutical composition
- carbazolona
- imidazolil
- methyl
- hydroxitriptamine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA PARA ADMINISTRACION RECTAL QUE COMPRENDE: 1) 1,2,3,9-TETRAHIDRO-9-METIL-3-((2-METIL-1H-IMIDAZOL-1-IL)-METIL)-4H-CARBAZOL-4-ONA DE FORMULA I; EN FORMA DE BASE LIBRE O UN SOLVATO A UNA CONCENTRACION DE 0,1 mg A 100 mg; PUDIENDO SER UTIL EN EL TRATAMIENTO DE LA NAUSEA Y EL VOMITO AL SER UN ANTAGONISTA DE LA 5-HIDROXITRIPTAMINA (5-HT); 2) EXCIPIENTES TALES COMO BASES GRASAS CON UN VALOR DE HIDROXILO DE 20 A 100, PUDIENDO PRESENTARSE EN UNA FORMA SOLIDA TAL COMO UN SUPOSITORIO
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939310756A GB9310756D0 (en) | 1993-05-25 | 1993-05-25 | Compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE13395A1 true PE13395A1 (es) | 1995-05-25 |
Family
ID=10736089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1994242905A PE13395A1 (es) | 1993-05-25 | 1994-05-23 | Composicion farmaceutica de imidazolil carbazolona |
Country Status (38)
| Country | Link |
|---|---|
| US (1) | US5741806A (es) |
| EP (1) | EP0700290B1 (es) |
| JP (1) | JP2965703B2 (es) |
| KR (1) | KR100297212B1 (es) |
| CN (1) | CN1106194C (es) |
| AP (1) | AP544A (es) |
| AT (1) | ATE183643T1 (es) |
| AU (1) | AU680918B2 (es) |
| BE (1) | BE1007158A3 (es) |
| BR (1) | BR1100046A (es) |
| CA (1) | CA2162919C (es) |
| CO (1) | CO4230094A1 (es) |
| CY (1) | CY2411B1 (es) |
| CZ (1) | CZ291041B6 (es) |
| DE (1) | DE69420266T2 (es) |
| DK (1) | DK0700290T3 (es) |
| EC (1) | ECSP941088A (es) |
| ES (1) | ES2136198T3 (es) |
| FR (1) | FR2705569B1 (es) |
| GB (2) | GB9310756D0 (es) |
| GR (1) | GR3031669T3 (es) |
| HR (2) | HRP940315B1 (es) |
| HU (1) | HU227121B1 (es) |
| IE (1) | IE80632B1 (es) |
| IL (1) | IL109749A (es) |
| IS (1) | IS1868B (es) |
| IT (1) | IT1272990B (es) |
| MY (1) | MY111445A (es) |
| NO (1) | NO306448B1 (es) |
| NZ (1) | NZ267415A (es) |
| PE (1) | PE13395A1 (es) |
| PL (1) | PL175578B1 (es) |
| RU (1) | RU2132684C1 (es) |
| SA (1) | SA94150003B1 (es) |
| SG (1) | SG48119A1 (es) |
| SI (1) | SI0700290T1 (es) |
| WO (1) | WO1994027599A1 (es) |
| ZA (1) | ZA943593B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1468685A3 (en) * | 1998-06-15 | 2004-12-15 | Sepracor Inc. | Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders |
| EP1464333A3 (en) * | 1998-06-15 | 2004-12-15 | Sepracor Inc. | Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders |
| TR200103757T2 (tr) * | 1998-06-15 | 2002-06-21 | Sepracor Inc. | Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı |
| IL140118A0 (en) * | 1998-06-15 | 2002-02-10 | Sepracor Inc | Use of optically pure (+) norcisapride for treating apnea, bulimia and other disorders |
| US6353005B1 (en) | 1999-03-02 | 2002-03-05 | Sepracor, Inc. | Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist |
| US6362202B1 (en) | 1999-03-02 | 2002-03-26 | Sepracor Inc. | Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists |
| BR0112969A (pt) * | 2000-08-04 | 2004-06-22 | Dmi Biosciences Inc | Método de utilização de dicetopiperazinas e composições contendo-as |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2561244B1 (fr) * | 1984-01-25 | 1988-03-04 | Glaxo Group Ltd | Composes heterocycliques du type tetrahydrocarbazolone, procede pour leur preparation et composition pharmaceutique les comprenant |
| US4695578A (en) * | 1984-01-25 | 1987-09-22 | Glaxo Group Limited | 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances |
| GB8627909D0 (en) * | 1986-11-21 | 1986-12-31 | Glaxo Group Ltd | Medicaments |
| GB8816187D0 (en) * | 1988-07-07 | 1988-08-10 | Glaxo Group Ltd | Medicaments |
| US5166145A (en) * | 1990-09-10 | 1992-11-24 | Alza Corporation | Antiemetic therapy |
-
1993
- 1993-05-25 GB GB939310756A patent/GB9310756D0/en active Pending
-
1994
- 1994-05-17 GB GB9409835A patent/GB2279008B/en not_active Expired - Lifetime
- 1994-05-17 SG SG1996007139A patent/SG48119A1/en unknown
- 1994-05-17 EC EC1994001088A patent/ECSP941088A/es unknown
- 1994-05-19 IS IS4168A patent/IS1868B/is unknown
- 1994-05-20 MY MYPI94001305A patent/MY111445A/en unknown
- 1994-05-23 CO CO94021615A patent/CO4230094A1/es unknown
- 1994-05-23 HR HR940315A patent/HRP940315B1/xx not_active IP Right Cessation
- 1994-05-23 AP APAP/P/1994/000643A patent/AP544A/en active
- 1994-05-23 PE PE1994242905A patent/PE13395A1/es not_active IP Right Cessation
- 1994-05-23 IE IE940420A patent/IE80632B1/en not_active IP Right Cessation
- 1994-05-24 RU RU95122578A patent/RU2132684C1/ru active
- 1994-05-24 PL PL94311721A patent/PL175578B1/pl unknown
- 1994-05-24 SI SI9430263T patent/SI0700290T1/xx unknown
- 1994-05-24 EP EP94918355A patent/EP0700290B1/en not_active Expired - Lifetime
- 1994-05-24 DE DE69420266T patent/DE69420266T2/de not_active Expired - Lifetime
- 1994-05-24 IT ITRM940322A patent/IT1272990B/it active IP Right Grant
- 1994-05-24 BE BE9400528A patent/BE1007158A3/fr not_active IP Right Cessation
- 1994-05-24 AT AT94918355T patent/ATE183643T1/de active
- 1994-05-24 DK DK94918355T patent/DK0700290T3/da active
- 1994-05-24 NZ NZ267415A patent/NZ267415A/en not_active IP Right Cessation
- 1994-05-24 ES ES94918355T patent/ES2136198T3/es not_active Expired - Lifetime
- 1994-05-24 AU AU69709/94A patent/AU680918B2/en not_active Expired
- 1994-05-24 KR KR1019950705280A patent/KR100297212B1/ko not_active IP Right Cessation
- 1994-05-24 FR FR9406252A patent/FR2705569B1/fr not_active Expired - Lifetime
- 1994-05-24 US US08/537,950 patent/US5741806A/en not_active Expired - Lifetime
- 1994-05-24 WO PCT/EP1994/001652 patent/WO1994027599A1/en active IP Right Grant
- 1994-05-24 CZ CZ19953085A patent/CZ291041B6/cs not_active IP Right Cessation
- 1994-05-24 JP JP7500204A patent/JP2965703B2/ja not_active Expired - Lifetime
- 1994-05-24 IL IL10974994A patent/IL109749A/en not_active IP Right Cessation
- 1994-05-24 CN CN94192243A patent/CN1106194C/zh not_active Expired - Lifetime
- 1994-05-24 ZA ZA943593A patent/ZA943593B/xx unknown
- 1994-05-24 HU HU9503375A patent/HU227121B1/hu unknown
- 1994-05-24 CA CA002162919A patent/CA2162919C/en not_active Expired - Lifetime
- 1994-06-12 SA SA94150003A patent/SA94150003B1/ar unknown
-
1995
- 1995-11-24 NO NO954783A patent/NO306448B1/no not_active IP Right Cessation
-
1996
- 1996-09-19 BR BR1100046-5A patent/BR1100046A/pt active IP Right Grant
-
1997
- 1997-06-09 HR HR970315A patent/HRP970315A2/hr not_active Application Discontinuation
-
1999
- 1999-10-27 GR GR990402759T patent/GR3031669T3/el unknown
-
2000
- 2000-06-06 CY CY0000022A patent/CY2411B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR029216A1 (es) | Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento | |
| CO5680109A1 (es) | Compuestos para el tratamiento de la disfuncion sexual femenina | |
| CO5261563A1 (es) | Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco | |
| AU1192302A (en) | Inhibition of emetic effect of metformin with 5-ht3 receptor antagonists | |
| KR870005637A (ko) | 약물 데포 | |
| ES2178037T3 (es) | Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que los contienen. | |
| AR037490A1 (es) | Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos | |
| CO4940406A1 (es) | Composiciones de paracetamol de accion rapida | |
| ES2175089T3 (es) | Una combinacion de un inhibidor de la absorcion de 5 - ht con un ant agonista selectivo de 5 ht1a. | |
| HUP0103203A2 (hu) | Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények | |
| DE69911023D1 (de) | Antagonisten des gonadotropin freisetzenden hormons | |
| PE13395A1 (es) | Composicion farmaceutica de imidazolil carbazolona | |
| AR018162A1 (es) | Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica | |
| ES2108130T3 (es) | Formulaciones farmacologicas mejoradas. | |
| DK0527081T3 (da) | Hidtil ukendte substituerede 3-piperazinylalkyl-2,3-dihydro-1,3-4H-benzoxazin-4-oner, deres fremstilling og terapeutiske anvendelse | |
| DE3873603D1 (de) | Zusammensetzung gegen coccidiosis. | |
| KR890006639A (ko) | 벤조티아진 디옥사이드 유도체 | |
| DE60101739D1 (de) | Makrolide | |
| IT1261471B (it) | Composizione farmaceutica per somministrazione rettale nel trattamentodi cefalea e relativo metodo di preparazione ed impiego. | |
| ES8200678A1 (es) | Un procedimiento para la produccion de 10-(4-piperidinil)-10, 11-dihidro-dibenzo b,f 1,4 oxarepinas; tiazepinas y diaze-pinas. | |
| AR031010A1 (es) | Una composicion farmaceutica, util para inhibir el dano celular | |
| BR0208655A (pt) | Composição farmacêuticas | |
| KR910002792A (ko) | 1-치환된-2-(3-아미노-1-프로피닐)피롤리딘 유도체, 그에 의한 중추 콜린성 기능 장해 치료 방법 및 그로구성되는 제약학적 조성물 | |
| AR022620A1 (es) | Aroil aminoacil pirroles para ser usados en el tratamiento de dolor neuropatico | |
| KR910019625A (ko) | 뼈의 무기질 소실을 억제하는 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| MK | Expiration of term |